compounding glp-1 enforcement news The FDA's Crackdown Continues: What to Know Troubling Findings in Study of

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

While insurance coverage can be a barrier for some, Refills makes access to effective, personalized treatment easier through convenient, online care and clear pricing

Although these digest slightly slower than whey, high-quality plant formulas can still support muscle recovery and maintenance when consumed consistently

This is incredibly dangerous and it reinforces what I have mentioned about the dangers of getting treatments or injections from dodgy, non-medical practitioners

H.HermansonD